The make DEEP Human Families Blog

Posts

September 29, 2026

New diabetes clinical trial: JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D

Published on: 2026-09-29T04:00:00Z Conditions : T1DM - Type 1 Diabetes Mellitus Interventions : Drug: Ivarmacitinib; Drug: Placebo Sponsors : Huijie Zhang Not yet recruiting https://ift.tt/6qngTmB

Search This Blog

The make DEEP Human Families Blog

Posts

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

TRANCEForm my Plate Seminars and DEEP Summit

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D

Latest Posts

New diabetes clinical trial: Gastrointestinal Symptoms in Children With Type 1 Diabetes

New diabetes clinical trial: Activity Reduction vs Advice for Plantar Hotspots in Diabetes

New diabetes clinical trial: Whole Food Fibers for Support of Key Gut Bacteria for Human Health

New diabetes clinical trial: Pre-Exercise Whey and Pea Protein in Adolescents With Type 1 Diabetes

New diabetes clinical trial: Cranberry Proanthocyanidins and Lactobacilli for Recurrent UTI Prevention in Type 2 Diabetes

New diabetes clinical trial: VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes

New diabetes clinical trial: Very-Low-Carbohydrate Diet for Prediabetes and Obesity

New diabetes clinical trial: Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia

New diabetes clinical trial: Diabetes Prevention AI: Enhancing Prevention Strategies Using Personalized Nutrition and Fitness Coaching for the Next Generation

New diabetes clinical trial: Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP)